From: Euiiyin-tang in the treatment of obesity: study protocol for a randomised controlled trial
Criteria for inclusion of participants |
---|
1. Women aged 18–65 years |
2. Patients who have any of the following conditions: |
2.1. BMI 30 kg/m2 or over |
2.2. Obese patients, BMI 27–29.9 kg/m2, who have more than one of the risk factors such as hypertension, diabetes, and hyperlipidaemia, and each of the conditions shall be subject to the following standards. |
2.3. Hypertension: Patients under adequate treatment after being diagnosed with hyperlipidaemia (BMI 27–29.9 kg/m2) and with their blood pressure adjusted (satisfying all the conditions of systolic blood pressure (SBP) ≤145 mmHg and diastolic blood pressure (DBP) ≤95 mmHg) |
2.4. Diabetes: Patients with insulin-independent diabetes mellitus adjusting fasting blood glucose <7.8 mmol/L (140 mg/dL) (BMI 27–29.9 kg/m2) |
2.5. Hyperlipidaemia: Patients under adequate treatment after being diagnosed with hyperlipidaemia (BMI 27–29.9 kg/m2) or with measurements of total cholesterol of more than 236 mg/dL or triglycerides of more than 150 mg/dL at screening |
3. Subjects who have agreed to a low-calorie diet during the trial |
4. Patients who have provided signed written consent for the trialform for |